About: Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring
Creator	Nolte, Frederick Dufour, D Gretch, David Koff, Raymond Lott, John Seeff, Leonard
Source	Medline; PMC
abstract	Purpose: To review information on the use of laboratory tests in screening, diagnosis, and monitoring of acute and chronic hepatic injury. Data Sources and Study Selection: A MEDLINE search was performed for key words related to hepatic diseases, including acute hepatitis, chronic hepatitis, alcoholic hepatitis, cirrhosis, hepatocellular carcinoma, and etiologic causes. Abstracts were reviewed, and articles discussing use of laboratory tests selected for review. Additional articles were selected from the references. Guideline Preparation and Review: Drafts of the guidelines were posted on the Internet, presented at the AACC Annual Meeting in 1999, and reviewed by experts. Areas requiring further amplification or literature review were identified for further analysis. Specific recommendations were made based on analysis of published data and evaluated for strength of evidence and clinical impact. Recommendations: Although many specific recommendations are made in the guidelines, only some summary recommendations are listed here. In acute hepatic injury, prothrombin time and, to a lesser extent, total bilirubin are the best indicators of severity of disease. Although ALT is useful for detecting acute and chronic hepatic injury, it is not related to severity of acute hepatic injury and only weakly related to severity of chronic hepatic injury. Specific tests of viral markers should be the initial differential tests in both acute and chronic hepatic injury; when positive, they are also useful for monitoring recovery from hepatitis B and C.
has issue date	2000-12-01(xsd:dateTime)
bibo:doi	10.1093/clinchem/46.12.2050
bibo:pmid	11106350
has license	no-cc
sha1sum (hex)	9852c8469166604b5b3be89bd2120f9ede9d6f08
schema:url	https://doi.org/10.1093/clinchem/46.12.2050
resource representing a document's title	Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring
has PubMed Central identifier	PMC7110382
has PubMed identifier	11106350
schema:publication	Clin Chem
resource representing a document's body	covid:9852c8469166604b5b3be89bd2120f9ede9d6f08#body_text
is schema:about of	named entity 'DIAGNOSIS' named entity 'HEPATIC INJURY' named entity 'Review' named entity 'articles' named entity 'disease' named entity 'selected' named entity 'hepatitis B' named entity 'RECOMMENDATIONS' named entity 'SELECTION' named entity 'STUDY' named entity 'CHRONIC HEPATIC' named entity 'ACUTE HEPATITIS' named entity 'ABSTRACTS' named entity 'PRESENTED' named entity 'EVALUATED' named entity 'HEPATIC INJURY' named entity 'ACUTE' named entity 'CIRRHOSIS' named entity 'MARKERS' named entity 'AREAS' named entity 'ANNUAL' named entity 'IMPACT' named entity 'CHRONIC HEPATITIS' named entity 'VIRAL' named entity 'DATA' named entity 'HERE' named entity 'KEY' named entity 'PROTHROMBIN TIME' named entity 'GUIDELINES' named entity 'CAUSES' named entity 'LABORATORY TESTS' named entity 'PERFORMED' named entity 'BASED' named entity 'GUIDELINES ' named entity 'CLINICAL' named entity 'INFORMATION' named entity 'HEPATIC DISEASES' named entity 'WORDS' named entity 'DISEASE' named entity 'SEARCH' named entity 'SEVERITY' named entity 'OF EVIDENCE' named entity 'ADDITIONAL' named entity 'TOTAL BILIRUBIN' named entity 'DIAGNOSIS' named entity 'MONITORING' named entity 'LITERATURE REVIEW' named entity 'SPECIFIC' named entity 'RELATED' named entity 'INITIAL' named entity 'REVIEWED' named entity 'MEETING' named entity 'HEPATITIS B' named entity 'SUMMARY' named entity 'MEDLINE' named entity 'REFERENCES' named entity 'SCREENING' named entity 'ALT' named entity 'RECOMMENDATIONS' named entity 'INCLUDING' named entity 'MONITORING' named entity 'USE OF' named entity 'LABORATORY TESTS' named entity 'ALCOHOLIC HEPATITIS' named entity 'DETECTING' named entity 'INDICATORS' named entity 'BEST' named entity 'ARTICLES' named entity 'POSITIVE' named entity 'USE OF' named entity 'GUIDELINE' named entity 'DATA SOURCES' named entity 'STRENGTH' named entity 'REVIEWED BY' named entity 'HEPATOCELLULAR CARCINOMA' named entity 'TESTS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software